ClinicalTrials.Veeva

Menu

EFFECTIVENESS OF THE NEUROADAPTATIVE FOR URGE INCONTINENCE (SCENAR-EC)

F

Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias

Status

Unknown

Conditions

Urge Incontinence

Treatments

Device: SCENAR 1NT-02.2

Study type

Interventional

Funder types

Other

Identifiers

NCT04164589
SCENAR-EC

Details and patient eligibility

About

In this clinical trials the sponsor want to assess a self-controlled-energo-neuroadaptative-regulation in patient with urge incontinence

Full description

In this clinical trials the sponsor want to assess a self-controlled-energo-neuroadaptative-regulation in patient with urge incontinence and mixted incontinence

Enrollment

62 estimated patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Urge incontinence or mixed incontinence without urethral hypermobility
  • Over 3 months of disease evolves.

Exclusion criteria

  • Severe physical limitations that might interfere with applying the treatment.
  • Severe mental disorders that need pharmacology treatments that may influence in neuronal activity
  • Oncological processes in the lower abdomen that had required radical surgery.
  • Neurogenic bladder.
  • Blockage of the bladder
  • Vaginal infection
  • Bladder infection or disorder of kidney function
  • Have received, in the last year, botulinum toxin in bladder or pelvic organs.
  • Have received pharmacological treatment for urge incontinence in the last month (before entry date in the trial)
  • Be receiving pharmacological treatment for urge incontinence.
  • Stress incontinence due to urethral hypermobility which was treatable with surgery.
  • Pregnant women
  • Patients with pacemarker

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

62 participants in 2 patient groups, including a placebo group

Control
Placebo Comparator group
Description:
The Neuro-Adaptative Regulation will be carried out in the regime of switched off power supply in vulvo-perineal and sacral area.
Treatment:
Device: SCENAR 1NT-02.2
Experimental
Experimental group
Description:
The neuro-adaptative regulation will be carried out in vulvo-perineal and sacarl area.
Treatment:
Device: SCENAR 1NT-02.2

Trial contacts and locations

1

Loading...

Central trial contact

Diana Barreira, Ph; Alvaro Zapico-Goñi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems